Oral milrinone for management of refractory right ventricular failure in patients with left ventricular assist devices

AIMS: We present a single‐centre retrospective experience using oral milrinone in patients with a left ventricular assist device (LVAD) and concurrent refractory right ventricular failure. METHODS AND RESULTS: All patients implanted with LVAD between January 2013 and July 2021 from a high‐volume adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Akhtar, Waqas, Butcher, Charles, Morley‐Smith, Andrew, Riesgo Gil, Fernando, Dar, Owais, Baston, Veronica, Dunning, John, Lyster, Haifa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773711/
https://www.ncbi.nlm.nih.gov/pubmed/35906098
http://dx.doi.org/10.1002/ehf2.14092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773711/
https://www.ncbi.nlm.nih.gov/pubmed/35906098
http://dx.doi.org/10.1002/ehf2.14092

Ejemplares similares